Naegleria fowleri: Difference between revisions

From IDWiki
Naegleria fowleri
(Created page with "* Protozoan parasite that causes '''primary amebic meningoencephalitis (PAM)''' * Found in warm fresh-water, including southern US * Infection (PAM) is rapidly-progressing and...")
 
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
  +
==Background==
* Protozoan parasite that causes '''primary amebic meningoencephalitis (PAM)'''
 
  +
===Microbiology===
  +
* One of the [[free-living amoebae]]
  +
  +
===Epidemiology===
 
* Found in warm fresh-water, including southern US
 
* Found in warm fresh-water, including southern US
* Infection (PAM) is rapidly-progressing and almost uniformly fatal
 
   
  +
==Clinical Manifestations==
 
* Causes acute, aggressive '''primary amebic meningoencephalitis''' (PAM)
 
* Infection (PAM) is rapidly-progressing and almost uniformly fatal (141/145 cases in the US)
  +
  +
==Management==
  +
* Unclear optimal management
  +
* CDC recommendations are:
  +
** [[Is treated by::Amphotericin B]] 0.75 mg/kg IV q12h for three days followed by 1 mg/kg IV daily for 11 days, concurrent with
  +
** [[Is treated by::Amphotericin B]] 1.5 mg intrathecal once daily for 2 days followed by 1 mg intrathecal q2d for 8 days, concurrent with
  +
** [[Is treated by::Azithromycin]] 10 mg/kg (max 500 mg) PO/IV daily, plus [[Is treated by::fluconazole]] 10 mg/kg (max 600 mg) PO/IV daily, plus [[Is treated by::rifampin]] 10 mg/kg (max 600 mg) PO/IV daily, plus [[Is treated by::miltefosine]] 50 mg PO bid or tid for 28 days, concurrent with
  +
** [[Is treated by::Dexamethasone]] 0.15 mg/kg IV q6h during the initial 4 days
 
{{DISPLAYTITLE:''Naegleria fowleri''}}
 
{{DISPLAYTITLE:''Naegleria fowleri''}}
  +
* Note that the recommendation is specifically for conventional rather than liposomal [[amphotericin B]]
  +
* [[Miltefosine]] dosing is bid if weight <45 kg and tid if weight ≥45 kg
  +
 
[[Category:Protozoa]]
 
[[Category:Protozoa]]

Latest revision as of 16:29, 18 February 2022

Background

Microbiology

Epidemiology

  • Found in warm fresh-water, including southern US

Clinical Manifestations

  • Causes acute, aggressive primary amebic meningoencephalitis (PAM)
  • Infection (PAM) is rapidly-progressing and almost uniformly fatal (141/145 cases in the US)

Management

  • Unclear optimal management
  • CDC recommendations are:
    • Amphotericin B 0.75 mg/kg IV q12h for three days followed by 1 mg/kg IV daily for 11 days, concurrent with
    • Amphotericin B 1.5 mg intrathecal once daily for 2 days followed by 1 mg intrathecal q2d for 8 days, concurrent with
    • Azithromycin 10 mg/kg (max 500 mg) PO/IV daily, plus fluconazole 10 mg/kg (max 600 mg) PO/IV daily, plus rifampin 10 mg/kg (max 600 mg) PO/IV daily, plus miltefosine 50 mg PO bid or tid for 28 days, concurrent with
    • Dexamethasone 0.15 mg/kg IV q6h during the initial 4 days
  • Note that the recommendation is specifically for conventional rather than liposomal amphotericin B
  • Miltefosine dosing is bid if weight <45 kg and tid if weight ≥45 kg